Welcome to the 2nd edition of our new Current Oncology Newsletter! As the publisher of Current Oncology, we would like to let you know about some upd

Welcome to the 2nd edition of our new Current Oncology Newsletter!

As the publisher of Current Oncology, we would like to let you know about some updates that we have made to our online submission and peer review system:

User Registration Page

We have enhanced our registration page for authors, reviewers and readers, to capture fields such as specialty and the province that our users practice in. We hope that this will aid in obtaining information about our readership so we are publishing articles that reach all fields of oncology relevant to professionals across Canada, and Internationally. If you haven’t registered with our site, we invite you to do so by clicking here. If you are already a registered user of the site, we ask that you take a moment to update your profile, by clicking here to log in, and clicking on “Edit my Profile”.

Simplifying the Peer Review Process

Based on feedback from our editors and reviewers, we are working toward simplifying the peer review process. Now, instead of logging into the system to complete the review, we have implemented a “One-click access” process. This feature allows editors to send reviewers an email message with a unique URL that goes directly to the review page for the article in question. The reviewer now has access in one simple click of the mouse! We are currently working on implementing more features to simplify the process...stay tuned for more information. If you have not yet registered as a reviewer, please click here.

Your feedback and comments are always welcome as we continue to work together, serving the Oncology community.


*Multimed Inc.*
Publisher of _Current Oncology_

The latest issue of Current Oncology is now available online. Please visit the following link to view full text articles from Volume 19, Number 2 (April 2012):


Future Table of Contents

The future table of contents for Current Oncology, Volume 19, Number 3 (June 2012) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:

Watch for the upcoming Supplement in May 2012!

Personalized Medicine in Metastatic NSCLC: A Canadian Perspective
Guest Editor, Dr. Vera Hirsh, has invited respected Canadian authorities in lung cancer to describe and discuss the topics related personalized medicine in metastatic NSCLC. This supplement will be published in both print & online. The goal of this supplement is to provide a complete review of present and future approaches to personalized medicine in advanced NSCLC in Canada.

Euthanasia Debate – A Special Series

In the June 2012 issue of Current Oncology we are publishing three manuscripts on the topic of Euthanasia & Assisted Suicide. We invite you to join us in the debate!


Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (March 2012)

A primer of bone metastases management in breast cancer patients
Petrut B, Trinkaus M, Simmons C, Clemons M
Curr Oncol. 2008 Jan;15(Suppl 1):S50-7

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
Melosky B, Burkes R, Rayson D, Alcindor T, Shear N, Lacouture M
Curr Oncol. 2009 Jan;16(1):16-26

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea
J.A. Maroun, L.B. Anthony, N. Blais, R. Burkes, S.D. Dowden, G. Dranitsaris, B. Samson, A. Shah, M.P. Thirlwell, M.D. Vincent, R. Wong
Curr Oncol. 2007 Feb; 14(1):13-20

Most Read Recently* Published Articles at www.current-oncology.com

Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls
Pereira J
Curr Oncol. 2011 Apr;18(2):e38-45

A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy
Lee CE, Leslie WD, Czaykowski P, Gingerich J, Geirnaert M, Lau YK
Curr Oncol. 2011 Aug;18(4):e163-72

A new standard of care for the management of peritoneal surface malignancy
Mohamed F, Cecil T, Moran B, Sugarbaker P
Curr Oncol. 2011 Apr;18(2):e84-96

*Published within past 12 months


April 22 is your last chance to save on registration for the UICC 2012 World Cancer Congress!

The UICC World Cancer Congress represents a unique and ideal platform for the international cancer control community to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of cancer on communities around the world.

Early-bird registration deadline for the UICC 2012 World Cancer Congress ends on April 22nd. Registering by April 22nd will allow organizations to take advantage of reduced rates, and save up to 60% on regular registration fees. Additionally, groups of five or more can register now at discounted rates, and provide names of delegates attending anytime before June.

For more information, visit http://www.worldcancercongress.org/registration

“Cancer System Indicator Snapshots” – A new series in Current Oncology

Starting with the June 2012 issue, the Canadian Partnership Against Cancer (CPAC) will be publishing a series of articles within Current Oncology entitled “Cancer System Indicator Snapshots”. The goal of this series is to present a sampling of the results from the partners’ collective efforts to measure their current status in cancer control.

The Québec Pancreas Cancer Study (QPCS) is enrolling patients and families affected by pancreatic cancer

The QPCS is a clinic-based study with the goal of characterizing the epidemiologic and hereditary factors associated with pancreatic cancer. Biospecimens are also being collected for biomarker, tumour biology, and cancer microenvironment investigations.

All patients with a diagnosis of pancreatic adenocarcinoma are eligible to participate. If there is a family history of pancreatic cancer, relatives of patients with pancreatic cancer may also participate. Patients and their relatives can be referred to the QPCS using our web site www.cancerpancreas.ca.

Study participants are asked to complete family and personal history questionnaires and to donate a blood or saliva sample. If a participant lives outside the Montreal area or is unable to attend the QPCS research clinic, collection of samples will be done at or close to the participant’s home. Only patients undergoing surgery at the McGill University Health Centre will be asked to donate a small portion of their resection specimen for tumour biology studies.

Each participant will have an opportunity to discuss the study with a QPCS genetic counsellor. The QPCS is affiliated with McGill University, the McGill University Health Centre and the Rosalind and Morris Goodman Cancer Research Centre. For more information, please see www.cancerpancreas.ca or contact Dr. George Zogopoulos.

Current Oncology publishes Meeting/Conference Abstracts and Proceedings

In our April 2012 issue we published selected abstracts submitted to the Fourth International Symposium on Hereditary Breast and Ovarian Cancer. As Canada’s premier Oncology journal, we aim to be the vehicle for meetings and conferences across Canada to maximize the impact of their findings and research presented. This can be accomplished by publishing your abstracts or a proceedings report in Current Oncology. For more information please contact Laura Hope.

Canadian Medical Association (CMA) Infobase

Recently the CMA requested to include the following article published in Current Oncology in their Infobase:
Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens.
Dawson AJ, McGowan–Jordan J, Chernos J, Xu J, Lavoie J, Wang JC, Steinraths M, and Shetty S
Curr Oncol. 2011 October; 18(5): e250–e255

The CMA Infobase is an electronic database of Canadian clinical practice guidelines maintained by the Canadian Medical Association. Its main purpose is to provide ready access to evidence-based, professionally endorsed statements to help Canadian physicians and physicians-in-training with their clinical practice and continuing medical education.

We are pleased to work with the CMA to help distribute relevant information to Canadian Physicians.


Contact Us

email facebook twitter